NeuDirection Limited Innovative Drugs in CNS disease Advancing Treatment for Neurological Challenges About us Explore Our Pipelines Our Mission Targeting unexplored G protein-coupled receptors (GPCRs) in the brain with novel small-molecule, neuropeptide mimetics for the treatment of rare and neglected Central Nervous System (CNS) diseases…… New Drug Pipelines Explore our innovative drug pipelines Amblyopia Neu-001, a novel small molecule agonist targeting a groundbreaking GPCR in the visual cortex, offers new hope for amblyopia patients. Tinnitus Neu-002, an innovative small molecule agonist targeting a key GPCR in the auditory cortex, presents a novel approach to treating tinnitus. Epilepsy Neu-003, a promising small molecule antagonist targeting a pivotal GPCR in the neocortex, represents a new frontier in epilepsy treatment. Do you have any question? Feel free to contact us anytime. Contact us now